ABTX
Business purpose.
conception, développement et production de molécules à visée thérapeutique dans le domaine de la clinique humaine ; recherche et développement dans le domaine de la biotechnologie.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 2 Jan 2024
- Share capital
- 31,597.00 EUR
- Financial year end
- 30/11
- Establishments
- 2
Directors
- Information not disclosable President de SAS
Other companies at the same address
52 other company head offices are registered at this address.
Establishments
-
98243688300028 69500 BRON
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
66 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (2.9 years)
- 5.7 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990
IDCC 1555 · repealed · 1 establishment · declared in July 2026
Legal notices
-
Amendment 21 Jul 2026
- Court :
- Greffe du Tribunal de Commerce de Dijon
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20260136, annonce n 876 · Proof of publication (PDF)
-
Filing of accounts 9 Jun 2026
- Court :
- Greffe du Tribunal de Commerce de dijon
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2025
BODACC C n 20260107, annonce n 2871 · Proof of publication (PDF)
-
Amendment 16 Nov 2025
- Court :
- Greffe du Tribunal de Commerce de Dijon
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20250220, annonce n 534 · Proof of publication (PDF)
-
Incorporation 14 Dec 2023
- Court :
- Greffe du Tribunal de Commerce de Dijon
BODACC A n 20230241, annonce n 197 · Proof of publication (PDF)
Filings and accounts
- Formality 12 Nov 2025
- Formality 18 Sep 2025
- Formality 26 May 2025
- Formality 26 May 2025
- Formality 12 Dec 2023
Change history
- officer_appointed (empty) → President de SAS 10 Oct 2026
- capital 31597.00 → 30000.00 1 Oct 2026
- capital 36356.00 → 31597.00 1 Oct 2026
- registered_address (empty) → 64 A Rue de Sully 21000 Dijon 1 Oct 2026
- capital (empty) → 36356.00 1 Oct 2026
Frequently asked questions about ABTX
- What is the SIREN number of ABTX?
- The SIREN number of ABTX is 982436883. Its intra-community VAT number is FR96982436883.
- Where is the head office of ABTX?
- Head office address: 64 A RUE SULLY, 21000 DIJON.
- When was ABTX founded?
- ABTX was founded on 2 Jan 2024.
- What does ABTX do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Is ABTX subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.